Whole genome sequencing informs treatment decision of end-stage metastatic cutaneous angiosarcoma in a patient with Xeroderma Pigmentosum
Whole genome sequencing informs treatment decision of end-stage metastatic cutaneous angiosarcoma in a patient with Xeroderma Pigmentosum
- 15/02/2019
- 2 samples
- DAC: EGAC00001000205
- Technology: HiSeq X Ten
Wellcome Trust Sanger Institute Data Sharing Policy
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001002610 | Cancer Genomics |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Quality Report |
Located in
i
|
|---|---|---|---|---|
| EGAF00002211249 | cram | 14.4 GB |
|
|
| EGAF00002211250 | cram | 17.5 GB |
|
|
| EGAF00002211251 | cram | 14.3 GB |
|
|
| EGAF00002211252 | cram | 17.4 GB |
|
|
| 4 Files (63.5 GB) | ||||
